Targeting Musashi-2 to counteract senescence and resistance in chronic myeloid leukemia: enhancing the efficacy of imatinib therapy

Arif K et al. BMC Cancer, December 2025 (epub ahead of print) – open access publication

• Share
• Tweet
• Share
• Share